Delivery Order SPE2DR25D1017-SPE2DR26F9CMV
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Ambien CR 6.25 mg tablets in quantities of 100 units, with a contract ceiling value of $3,247.94. This is a firm fixed-price delivery order with an ultimate completion date of August 29, 2025, and represents a competitively awarded, non-set-aside contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Ambien CR 6.25 mg tablets (100-count units) with a contract ceiling value of $1,501.57. This competitively awarded, firm fixed-price delivery order has an ultimate completion date of August 12, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 22, 2025, for the supply of Ambien CR 6.25 mg tablets (100 count) valued at $2,725.49. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of 100 tablets of Ambien CR 6.25 mg with a ceiling value of $6,913.68. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract has an ultimate completion date of July 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count) under a firm fixed-price contract valued at $3,266.24. The award was made on September 11, 2025, with an ultimate completion date of September 12, 2025, and represents a non-competitive delivery order without set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Ambien CR 6.25 mg tablets in quantities of 100 units, with a ceiling value of $2,094.39. This competitively awarded, non-set-aside delivery order represents a firm fixed price contract with an ultimate completion date of September 24, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company serves as a major...
- The Defense Logistics Agency awarded a delivery order valued at $1,493.76 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets in quantities of 100 units. This firm fixed-price, competitively awarded delivery order was issued on November 18, 2025, with an ultimate completion date of November 19, 2025. The contract utilizes no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $4,360.04 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count units) on September 5, 2025, with an ultimate completion date of September 8, 2025. This competitive award utilizes firm fixed pricing and carries no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters and a major distribution hub for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Ambien CR 6.25 mg tablets in quantities of 100, with a contract ceiling value of $2,038.30. This non-competitive delivery order represents a firm fixed-price transaction and is scheduled for completion by December 16, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract, this delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Ambien CR 6.25 mg tablets (100-count units) with a contract ceiling value of $2,237.57. This is a firm fixed price delivery order with no set-aside designation, indicating the award was competitively procured. The order is scheduled for completion by September 22, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9CMVDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Ambien CR 6.25 mg tablets (100 count) with a ceiling value of $3,761.57. This is a firm fixed-price delivery order with an ultimate completion date of January 6, 2026, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The DLA Troop Support Medical contract reflects the company's established capability to fulfill federal medical procurement requirements through open competition and demonstrates its role as a critical pharmaceutical distributor for the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 1/4/26 |